G1 Therapeutics, Inc.;The Board of Trustees of the University of Illinois
发明人:
Strum, Jay C.,Thatcher, Gregory R.,Xiong, Rui,Zhao, Jiong,Tonetti, Debra A.
申请号:
AU2018205262
公开号:
AU2018205262A1
申请日:
2018.01.05
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
Compositions, combinations and methods comprising the administration of a CDK4/6 inhibitor of Formula D with a selective estrogen receptor downregulator of Formula A, B or C that are advantageous for the treatment of abnormal cellular proliferation, including a cancer or a tumor.